Movie Industry

'Odyssey' Attracted 1.33 Million Viewers Over the Weekend Alone… Tops the Charts for the Fifth Consecutive Day, Overtaking 'Spider-Man 4'

Director Christopher Nolan's New Film, 'The Odyssey'

Choi Hee-jae
2026-08-10 08:26:07
[Edaily Starin Reporter Choi Hee-jae ] The movie "The Odyssey" is on a box office roll, topping the charts for five consecutive days since its release.
Poster for the movie “The Odyssey” (Photo: Universal Pictures)

According to the Korean Film Council’s integrated computer network on the 10th, “The Odyssey” drew 1,333,436 viewers over the weekend from the 7th to the 9th, taking the top spot at the box office. Its cumulative audience count stands at 1,874,730.
“The Odyssey” has held the No. 1 spot at the box office for five consecutive days since its release, overtaking “Spider-Man: Brand New Day” (Spider-Man 4).
“Spider-Man 4” continues its run, holding onto the No. 2 spot. Released on the 29th of last month, “Spider-Man 4” drew 1,264,530 viewers over the three-day weekend, bringing its cumulative total to 5,911,932.
In third place is the Korean animated film *Love Hachuping: The Legend of the Whale Gem* (*Hachuping 2*), which drew 289,446 viewers over the weekend, demonstrating the enduring appeal of the popular character “Hachuping.”
“Hope” took fourth place with 100,889 weekend viewers, bringing its cumulative total to 4.39 million. Fifth place went to “David,” which drew 16,861 viewers.
“Odyssey,” which tells an epic myth, and the superhero blockbuster “Spider-Man 4” are both enjoying strong box office success. Amid fierce competition in the summer movie season, Korean films “Okay Madam 2” and “Gyeongju Journey” are also set to be released soon.

Economy

Corporation

IT·Science

Economy

"Why Should I Buy That Apartment for You?"... Will It Take 30 Years for Gen Z and Millennials to Buy a Home in Seoul?

(Photo: Blind) One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
2026-10-04 12:00:03

Corporation

GI Innovation and G2G Bio Jump 20% on Hopes for a Licensing Deal [K-bio pulse]

The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
2026-10-03 07:22:03

IT·Science

Roche’s Choice: HanmiPharm’s New Obesity Drug; Vice President Choi In-young: “We Wanted to Lose Fat and Gain Muscle”

Lose fat while preserving muscle. As Roche has discontinued emugrovat—a candidate it was developing to counteract muscle loss during obesity treatment—the role of “HM17321,” a technology licensed by H…
2026-10-05 07:16:02